Suscribirse

Enhanced osteoblastic differentiation and bone formation in co-culture of human bone marrow mesenchymal stromal cells and peripheral blood mononuclear cells with exogenous VEGF - 06/05/15

Doi : 10.1016/j.otsr.2015.01.014 
K. Joensuu a, , L. Uusitalo a, J.J. Alm b, H.T. Aro b, T.A. Hentunen a, T.J. Heino a, b
a Department of Cell Biology and Anatomy, Kiinamyllynkatu 10 C3, 20520 Turku, Finland 
b Orthopedic Research Unit, Department of Orthopedic Surgery and Traumatology, University of Turku, Turku, Finland 

Corresponding author. Tel.: +358443371988; fax: +358 2 231 0320.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Despite recent advances in bone tissue engineering, efficient bone formation and vascularization remains a challenge for clinical applications.

Hypothesis

The aim of this study was to investigate if the osteoblastic differentiation of human mesenchymal stromal cells (MSCs) can be enhanced by co-culturing them with peripheral blood (PB) mononuclear cells (MNCs), with and without vascular endothelial growth factor (VEGF), a coupling factor of bone formation and angiogenesis.

Materials and methods

Human bone marrow (BM) derived MSCs were co-cultured with PB-MNCs in osteogenic medium with or without VEGF. Osteoblastic differentiation and mineral deposition were studied by staining for alkaline phosphatase (ALP), and von Kossa, respectively, and measurements for ALP activity and calcium concentration (Ca). Cell proliferation was assayed with Alamar blue. The mechanism(s) were further studied by Transwell® cell culture experiments.

Results

Both ALP and mineralization (von Kossa and Ca) were significantly higher in the MSC-MNC co-cultures compared to plain MSC cultures. VEGF alone had no effect on osteoblastic differentiation of MSCs, but further enhanced differentiation in co-culture settings. The mechanism was shown to require cell-cell contact between MSCs and MNCs and the factors contributing to further differentiation appear to be soluble. No differences were observed in cell proliferation.

Conclusion

Our study demonstrates that the in vitro ALP activity and mineralization of human BM-MSCs is more efficient in the presence of PB-MNCs, and exogenously added VEGF further enhances the stimulatory effect. This indicates that PB-MNCs could be a potential cell source in development of co-culture systems for novel tissue engineering applications for enhanced bone healing.

Level of evidence

Level IV. Experimental research study.

El texto completo de este artículo está disponible en PDF.

Keywords : Mesenchymal stromal cells, Mononuclear cells, Osteoblastic differentiation, Tissue engineering, Vascular endothelial growth factor


Esquema


© 2015  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 101 - N° 3

P. 381-386 - mai 2015 Regresar al número
Artículo precedente Artículo precedente
  • Degenerative facet joint changes in lumbar percutaneous pedicle screw fixation without fusion
  • L. Proietti, L. Scaramuzzo, G.R. Schirò, S. Sessa, F.C. Tamburrelli, G. Cerulli
| Artículo siguiente Artículo siguiente
  • Interest of including trauma photography in the picture archiving and communication system of a teaching hospital
  • N. Bronsard, B. Chignon Sicard, N. Amoretti, H. Rottier, P. Ertz, F. de Peretti

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.